These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 21170360)

  • 1. HIV capsid is a tractable target for small molecule therapeutic intervention.
    Blair WS; Pickford C; Irving SL; Brown DG; Anderson M; Bazin R; Cao J; Ciaramella G; Isaacson J; Jackson L; Hunt R; Kjerrstrom A; Nieman JA; Patick AK; Perros M; Scott AD; Whitby K; Wu H; Butler SL
    PLoS Pathog; 2010 Dec; 6(12):e1001220. PubMed ID: 21170360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel small-molecule HIV-1 replication inhibitors that stabilize capsid complexes.
    Lamorte L; Titolo S; Lemke CT; Goudreau N; Mercier JF; Wardrop E; Shah VB; von Schwedler UK; Langelier C; Banik SS; Aiken C; Sundquist WI; Mason SW
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4622-31. PubMed ID: 23817385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HIV-1 Maturation via Small-Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein.
    Wang W; Zhou J; Halambage UD; Jurado KA; Jamin AV; Wang Y; Engelman AN; Aiken C
    J Virol; 2017 May; 91(9):. PubMed ID: 28202766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization.
    Shi J; Zhou J; Shah VB; Aiken C; Whitby K
    J Virol; 2011 Jan; 85(1):542-9. PubMed ID: 20962083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibiting early-stage events in HIV-1 replication by small-molecule targeting of the HIV-1 capsid.
    Kortagere S; Madani N; Mankowski MK; Schön A; Zentner I; Swaminathan G; Princiotto A; Anthony K; Oza A; Sierra LJ; Passic SR; Wang X; Jones DM; Stavale E; Krebs FC; Martín-García J; Freire E; Ptak RG; Sodroski J; Cocklin S; Smith AB
    J Virol; 2012 Aug; 86(16):8472-81. PubMed ID: 22647699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural-product-library-based screening for discovery of capsid C-terminal domain targeted HIV-1 inhibitors.
    Zhang DW; Luo RH; Xu L; Yang LM; Xu XS; Zheng YT; Luo H
    Int J Antimicrob Agents; 2020 Apr; 55(4):105926. PubMed ID: 32092396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities.
    Sun L; Dick A; Meuser ME; Huang T; Zalloum WA; Chen CH; Cherukupalli S; Xu S; Ding X; Gao P; Kang D; De Clercq E; Pannecouque C; Cocklin S; Lee KH; Liu X; Zhan P
    J Med Chem; 2020 May; 63(9):4790-4810. PubMed ID: 32298111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ebselen, a Small-Molecule Capsid Inhibitor of HIV-1 Replication.
    Thenin-Houssier S; de Vera IM; Pedro-Rosa L; Brady A; Richard A; Konnick B; Opp S; Buffone C; Fuhrmann J; Kota S; Billack B; Pietka-Ottlik M; Tellinghuisen T; Choe H; Spicer T; Scampavia L; Diaz-Griffero F; Kojetin DJ; Valente ST
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2195-208. PubMed ID: 26810656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct effects of two HIV-1 capsid assembly inhibitor families that bind the same site within the N-terminal domain of the viral CA protein.
    Lemke CT; Titolo S; von Schwedler U; Goudreau N; Mercier JF; Wardrop E; Faucher AM; Coulombe R; Banik SS; Fader L; Gagnon A; Kawai SH; Rancourt J; Tremblay M; Yoakim C; Simoneau B; Archambault J; Sundquist WI; Mason SW
    J Virol; 2012 Jun; 86(12):6643-55. PubMed ID: 22496222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 Resistance to the Capsid-Targeting Inhibitor PF74 Results in Altered Dependence on Host Factors Required for Virus Nuclear Entry.
    Zhou J; Price AJ; Halambage UD; James LC; Aiken C
    J Virol; 2015 Sep; 89(17):9068-79. PubMed ID: 26109731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel inhibitor binding site discovery on HIV-1 capsid N-terminal domain by NMR and X-ray crystallography.
    Goudreau N; Lemke CT; Faucher AM; Grand-Maître C; Goulet S; Lacoste JE; Rancourt J; Malenfant E; Mercier JF; Titolo S; Mason SW
    ACS Chem Biol; 2013 May; 8(5):1074-82. PubMed ID: 23496828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical profiling of HIV-1 capsid-targeting antiviral PF74.
    Wang L; Casey MC; Vernekar SKV; Do HT; Sahani RL; Kirby KA; Du H; Hachiya A; Zhang H; Tedbury PR; Xie J; Sarafianos SG; Wang Z
    Eur J Med Chem; 2020 Aug; 200():112427. PubMed ID: 32438252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical targeting of HIV capsid protein with a long-acting small molecule.
    Link JO; Rhee MS; Tse WC; Zheng J; Somoza JR; Rowe W; Begley R; Chiu A; Mulato A; Hansen D; Singer E; Tsai LK; Bam RA; Chou CH; Canales E; Brizgys G; Zhang JR; Li J; Graupe M; Morganelli P; Liu Q; Wu Q; Halcomb RL; Saito RD; Schroeder SD; Lazerwith SE; Bondy S; Jin D; Hung M; Novikov N; Liu X; Villaseñor AG; Cannizzaro CE; Hu EY; Anderson RL; Appleby TC; Lu B; Mwangi J; Liclican A; Niedziela-Majka A; Papalia GA; Wong MH; Leavitt SA; Xu Y; Koditek D; Stepan GJ; Yu H; Pagratis N; Clancy S; Ahmadyar S; Cai TZ; Sellers S; Wolckenhauer SA; Ling J; Callebaut C; Margot N; Ram RR; Liu YP; Hyland R; Sinclair GI; Ruane PJ; Crofoot GE; McDonald CK; Brainard DM; Lad L; Swaminathan S; Sundquist WI; Sakowicz R; Chester AE; Lee WE; Daar ES; Yant SR; Cihlar T
    Nature; 2020 Aug; 584(7822):614-618. PubMed ID: 32612233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alkyl Amine Bevirimat Derivatives Are Potent and Broadly Active HIV-1 Maturation Inhibitors.
    Urano E; Ablan SD; Mandt R; Pauly GT; Sigano DM; Schneider JP; Martin DE; Nitz TJ; Wild CT; Freed EO
    Antimicrob Agents Chemother; 2016 Jan; 60(1):190-7. PubMed ID: 26482309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compensatory substitutions in the HIV-1 capsid reduce the fitness cost associated with resistance to a capsid-targeting small-molecule inhibitor.
    Shi J; Zhou J; Halambage UD; Shah VB; Burse MJ; Wu H; Blair WS; Butler SL; Aiken C
    J Virol; 2015 Jan; 89(1):208-19. PubMed ID: 25320302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity relationships of a novel capsid targeted inhibitor of HIV-1 replication.
    Kortagere S; Xu JP; Mankowski MK; Ptak RG; Cocklin S
    J Chem Inf Model; 2014 Nov; 54(11):3080-90. PubMed ID: 25302989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activities.
    Sun L; Huang T; Dick A; Meuser ME; Zalloum WA; Chen CH; Ding X; Gao P; Cocklin S; Lee KH; Zhan P; Liu X
    Eur J Med Chem; 2020 Mar; 190():112085. PubMed ID: 32066010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 Capsid Inhibitors as Antiretroviral Agents.
    Thenin-Houssier S; Valente ST
    Curr HIV Res; 2016; 14(3):270-82. PubMed ID: 26957201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and mechanistic investigations of phenylalanine derivatives containing a benzothiazole moiety as HIV-1 capsid inhibitors with improved metabolic stability.
    Xu S; Sun L; Dick A; Zalloum WA; Huang T; Meuser ME; Zhang X; Tao Y; Cherukupalli S; Ding D; Ding X; Gao S; Jiang X; Kang D; De Clercq E; Pannecouque C; Cocklin S; Liu X; Zhan P
    Eur J Med Chem; 2022 Jan; 227():113903. PubMed ID: 34653770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A HTRF based competitive binding assay for screening specific inhibitors of HIV-1 capsid assembly targeting the C-Terminal domain of capsid.
    Zhang DW; Luo RH; Xu L; Yang LM; Xu XS; Bedwell GJ; Engelman AN; Zheng YT; Chang S
    Antiviral Res; 2019 Sep; 169():104544. PubMed ID: 31254557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.